Sidley Austin and Moelis & Company have advised ARCHIMED. Goodwin Procter and Centerview Partners have advised Esperion Therapeutics. Akin Gump has advised Pharmakon Advisors. ARCHIMED, a...
ARCHIMED Acquires Esperion Therapeutics in $1.1 Billion Transaction
Opus Genetics Secures $155 Million Structured Financing from Oberland Capital
Sidley has advised Opus Genetics on the deal. Opus Genetics, Inc., a clinical-stage gene therapy company focused on inherited retinal diseases, has entered into a strategic...
Precision NeuroMed and Brainlab Announce Strategic Partnership for AI-Enabled Brain Drug Delivery Platform
Sidley has advised Precision NeuroMed Inc. on the deal. Precision NeuroMed Inc. (PNM), a clinical-stage biotechnology company, has entered a strategic partnership with Brainlab SE, a...
Sensei Biotherapeutics Acquires Faeth Therapeutics and Raises US$200 Million in Private Placement
Sidley has advised Sensei Biotherapeutics on the deal. Sensei Biotherapeutics, Inc. has completed the acquisition of Faeth Therapeutics and undertaken a private placement expected to generate...
Sensei Biotherapeutics Acquires Faeth Therapeutics
Sidley has advised Sensei Biotherapeutic on the transaction. Cooley has advised Faeth Therapeutics. Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a Nasdaq-listed clinical-stage biotechnology company, has acquired Faeth...
Mosaic Clinical Technologies Acquires Cognita Imaging to Advance Radiology AI
Dechert has advised Cognita Imaging Inc. Sidley has advised Radiology Partners and its subsidiary Mosaic Clinical Technologies. Mosaic Clinical Technologies, the technology and AI services division...
Spire Acquires Piedmont Natural Gas Tennessee Operations from Duke Energy for $2.48 Billion
Sidley has advised Spire Inc.; Skadden has advised Duke Energy. In addition, Duke Energy received legal support on certain regulatory matters from McGuireWoods and Holland &...
Vera Therapeutics’ Exclusive License Agreement with Stanford University
Sidley Austin represented Vera Therapeutics, Inc. in the transaction. Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments...
Eagle Materials’ $152.5 Million Acquisition of Bullskin Stone & Lime
Sidley Austin is advising Eagle Materials Inc. on the transaction Eagle Materials Inc. (NYSE: EXP) announced it has entered into a definitive agreement to acquire Bullskin...
Verona Pharma’s $650 Million Financing Round
Sidley Austin represented OMERS Life Sciences in the transaction, while Latham & Watkins advised Verona Pharma and Sullivan & Cromwell represented Oaktree Capital Management, L.P. Verona...
BigHat Biosciences’ Licensing Collaboration With Synaffix B.V.
Sidley Austin represented BigHat Biosciences, Inc. in the transaction. BigHat Biosciences, Inc. (“BigHat”), announced a licensing collaboration with Synaffix B.V. (“Synaffix”), a Lonza company (SWX:LONN). BigHat’s...
BigHat Biosciences’ Collaboration with Janssen Biotech
Sidley Austin represented BigHat Biosciences in the transaction. BigHat Biosciences, a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform, announced its collaboration...